| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adoption of Pharmaceutical Innovation and the Growth of Drug Expenditure in Taiwan: Is It Cost Effective?
|
Hsieh, Chee-Ruey
|
|
2008
|
11 |
Supplement 1 |
p. 334-344
11 p.
|
artikel
|
| 2 |
A Modeled Economic Evaluation Comparing Atomoxetine with Stimulant Therapy in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder in the United Kingdom
|
Cottrell, Suzi
|
|
2008
|
11 |
Supplement 1 |
p. 376-388
13 p.
|
artikel
|
| 3 |
Applying the Expectancy-Value Model to Understand Health Values
|
Zhang, Xu-Hao
|
|
2008
|
11 |
Supplement 1 |
p. S61-S68
8 p.
|
artikel
|
| 4 |
A Randomized Controlled Trial of the Cost-Utility of Second-Generation Antipsychotics in People with Psychosis and Eligible for Clozapine
|
Davies, Linda M.
|
|
2008
|
11 |
Supplement 1 |
p. 549-562
14 p.
|
artikel
|
| 5 |
Are N-of-1 Trials an Economically Viable Option to Improve Access to Selected High Cost Medications? The Australian Experience
|
Scuffham, Paul A.
|
|
2008
|
11 |
Supplement 1 |
p. 97-109
13 p.
|
artikel
|
| 6 |
A Study on Indirect and Intangible Costs for Patients with Knee Osteoarthritis in Singapore
|
Xie, Feng
|
|
2008
|
11 |
Supplement 1 |
p. S84-S90
7 p.
|
artikel
|
| 7 |
CASE 1 AN INTEGRATED PILOT PROJECT UTILIZING AN INTERNAL HTA PROCESSTO SET MEDICALAND PAYMENT POLICY IN A U.S. COMMERCIAL HEALTH PLAN
|
Watkins, J
|
|
2008
|
11 |
Supplement 1 |
p. A1-
1 p.
|
artikel
|
| 8 |
CASE 2 DRUG ELUTING STENTS—AN EXAMPLE OFTHETRANSITION FROM EVIDENCETO POLICYTHROUGHTHE ONTARIO COMPREHENSIVE APPROACHTOTHE DIFFUSION OF HEALTHTECHNOLOGIES
|
Levin, L
|
|
2008
|
11 |
Supplement 1 |
p. A1-A2
nvt p.
|
artikel
|
| 9 |
Cholesterol Goal Attainment in Patients with Coronary Heart Disease and Elevated Coronary Risk: Results of the Hong Kong Hospital Audit Study
|
Lee, Kenneth K.C.
|
|
2008
|
11 |
Supplement 1 |
p. S91-S98
8 p.
|
artikel
|
| 10 |
Citizen's Preferences Regarding Principles to Guide Health-Care Allocation Decisions in Thailand
|
Kasemsup, Vijj
|
|
2008
|
11 |
Supplement 1 |
p. 1194-1202
9 p.
|
artikel
|
| 11 |
Classifying Patients by Antipsychotic Adherence Patterns Using Latent Class Analysis: Characteristics of Nonadherent Groups in the California Medicaid (Medi-Cal) Program
|
Ahn, Jeonghoon
|
|
2008
|
11 |
Supplement 1 |
p. 48-56
9 p.
|
artikel
|
| 12 |
Clustering of Cardiovascular Disease Risk Factors and Health-Related Quality of Life among US Adults
|
Li, Chaoyang
|
|
2008
|
11 |
Supplement 1 |
p. 689-699
11 p.
|
artikel
|
| 13 |
Comparison of the Initial Hospitalization Costs between the Patients Treated with Dobutamine and the Patients Treated with Amrinone for Acute Decompensated Heart Failure in a Japanese Institute
|
Komamura, Kazuo
|
|
2008
|
11 |
Supplement 1 |
p. S39-S42
4 p.
|
artikel
|
| 14 |
Cost-Effectiveness of a Low-Calorie Diet and Orlistat for Obese Persons: Modeling Long-Term Health Gains through Prevention of Obesity-Related Chronic Diseases
|
van Baal, Pieter H.M.
|
|
2008
|
11 |
Supplement 1 |
p. 1033-1040
8 p.
|
artikel
|
| 15 |
Cost-Effectiveness of Pemetrexed Plus Cisplatin: Malignant Pleural Mesothelioma Treatment in UK Clinical Practice
|
Cordony, Anna
|
|
2008
|
11 |
Supplement 1 |
p. 4-12
9 p.
|
artikel
|
| 16 |
Cost-Effectiveness Study Comparing Cefoperazone-Sulbactam to a Three-Drug Combination for Treating Intraabdominal Infections in an Indian Health-Care Setting
|
Kochhar, Puja
|
|
2008
|
11 |
Supplement 1 |
p. S33-S38
6 p.
|
artikel
|
| 17 |
Cost-Utility Analysis of Rimonabant in the Treatment of Obesity
|
Hampp, Christian
|
|
2008
|
11 |
Supplement 1 |
p. 389-399
11 p.
|
artikel
|
| 18 |
DB1 ESTIMATING THE LONG-TERM CLINICAL AND ECONOMIC BENEFITS OF INSULIN LISPRO IN TYPE 1 DIABETES IN THE UNITED KINGDOM: A COST-EFFECTIVENESS ANALYSIS BASED ON THE RESULTS OF A RECENT META-ANALYSIS
|
Smith, HT
|
|
2008
|
11 |
Supplement 1 |
p. A358-
1 p.
|
artikel
|
| 19 |
DB3 HEALTH CARE RESOURCE UTILIZATION AND COSTS IN INSULIN-DEPENDENT PATIENTS WITH TYPE 2 DIABETES UNDER REALWORLD CONDITIONS IN GERMANY: LIVE-SPP STUDY
|
Schöffski, O
|
|
2008
|
11 |
Supplement 1 |
p. A359-
1 p.
|
artikel
|
| 20 |
DB1 REAL-WORLD SIX MONTH OUTCOMES OF PATIENTS INITIATING EXENATIDE IN A PRIMARY CARE ELECTRONIC MEDICAL RECORD DATABASE
|
Brixner, D
|
|
2008
|
11 |
Supplement 1 |
p. A17-
1 p.
|
artikel
|
| 21 |
DB4 RETROSPECTIVE STUDY OF TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS NOT OPTIMALLY CONTROLLED BY METFORMIN MONOTHERAPY
|
He, J
|
|
2008
|
11 |
Supplement 1 |
p. A18-
1 p.
|
artikel
|
| 22 |
Deterioration of Quality of Life of High-Risk Breast Cancer Patients Treated with High-Dose Chemotherapy: The PEGASE 01 Quality of Life Study
|
Marino, Patricia
|
|
2008
|
11 |
Supplement 1 |
p. 709-718
10 p.
|
artikel
|
| 23 |
Development and Validation of the “Treatment Satisfaction with Medicines Questionnaire” (SATMED-Q)©
|
Ruiz, Miguel A.
|
|
2008
|
11 |
Supplement 1 |
p. 913-926
14 p.
|
artikel
|
| 24 |
Does Epoetin Alfa Improve Health-Related Quality of Life in Chronically Ill Patients with Anemia? Summary of Trials of Cancer, HIV/AIDS, and Chronic Kidney Disease
|
Kimel, Miriam
|
|
2008
|
11 |
Supplement 1 |
p. 57-75
19 p.
|
artikel
|
| 25 |
Drotrecogin Alfa's Impact on Intensive Care Workload in Real Life Practice: A Propensity Score Approach
|
Riou França, Lionel
|
|
2008
|
11 |
Supplement 1 |
p. 1051-1060
10 p.
|
artikel
|
| 26 |
Drug Safety Surveillance in China and Other Countries: A Review and Comparison
|
Du, Wenmin
|
|
2008
|
11 |
Supplement 1 |
p. S130-S136
7 p.
|
artikel
|
| 27 |
DU6 ASSESSMENT OF DRUG UTILIZATION PATTERNS AND COSTS FOR ERYTHROPOIETIC STIMULATING AGENTS IN ELDERLY PATIENTS WITH CHRONIC KIDNEY DISEASE
|
Lafeuille, MH
|
|
2008
|
11 |
Supplement 1 |
p. A23-
1 p.
|
artikel
|
| 28 |
Economic Implications of Entecavir Treatment in Suppressing Viral Replication in Chronic Hepatitis B (CHB) Patients in China from a Perspective of the Chinese Social Security Program
|
Yuan, Yong
|
|
2008
|
11 |
Supplement 1 |
p. S11-S22
12 p.
|
artikel
|
| 29 |
Evaluation of New Measures of the Impact of Hypothyroidism on Quality of Life and Symptoms: The ThyDQoL and ThySRQ
|
McMillan, Carolyn
|
|
2008
|
11 |
Supplement 1 |
p. 285-294
10 p.
|
artikel
|
| 30 |
Expected Value of Perfect Information: An Empirical Example of Reducing Decision Uncertainty by Conducting Additional Research
|
Oostenbrink, Jan B.
|
|
2008
|
11 |
Supplement 1 |
p. 1070-1080
11 p.
|
artikel
|
| 31 |
Factors Affecting Health-Care Costs and Hospitalizations among Diabetic Patients in Thai Public Hospitals
|
Chaikledkaew, Usa
|
|
2008
|
11 |
Supplement 1 |
p. S69-S74
6 p.
|
artikel
|
| 32 |
HBeAg-Negative Chronic Hepatitis B: Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine in Taiwan
|
Veenstra, David L.
|
|
2008
|
11 |
Supplement 1 |
p. 131-138
8 p.
|
artikel
|
| 33 |
HT4 HEALTH TECHNOLOGY ASSESSMENTS: ARE THEY RELEVANT TO CLINICAL PRACTICE?
|
Zhang, B
|
|
2008
|
11 |
Supplement 1 |
p. A338-A339
nvt p.
|
artikel
|
| 34 |
Lipid Testing among Patients Beginning Statin Therapy in General Practice in the United Kingdom
|
Phatak, Hemant
|
|
2008
|
11 |
Supplement 1 |
p. 933-938
6 p.
|
artikel
|
| 35 |
MD7 DIFFERENTIALTAKE-UP OFTHE MEDICARE PART D PRESCRIPTION DRUG BENEFIT
|
Rabbani, A
|
|
2008
|
11 |
Supplement 1 |
p. A12-A13
nvt p.
|
artikel
|
| 36 |
MD1 HEALTH ECONOMIC ANALYSIS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION COMPARED TO MULTIPLE DAILY INJECTIONS FOR THE TREATMENT OF TYPE 1 DIABETES IN POLAND
|
Clegg, JP
|
|
2008
|
11 |
Supplement 1 |
p. A336-
1 p.
|
artikel
|
| 37 |
MH5 EFFECT OF A NURSE TELEPHONE FOLLOW-UP ON THERAPEUTIC ADHERENCE OF PATIENTS WITH SCHIZOPHRENIA
|
Maurino, J
|
|
2008
|
11 |
Supplement 1 |
p. A344-
1 p.
|
artikel
|
| 38 |
MH1 REAL WORLD ASSOCIATION BETWEEN ANTIPSYCHOTIC TREATMENT AND WEIGHT GAIN IN AN ADOLESCENT POPULATION
|
Ghate, SR
|
|
2008
|
11 |
Supplement 1 |
p. A6-A7
nvt p.
|
artikel
|
| 39 |
MH4 TREATMENT COST AND COMORBIDITIES ASSOCIATEDWITH OBESITY AMONG CHILDREN ANDADOLESCENTSWITH BIPOLAR DISORDER
|
Guo, JJ
|
|
2008
|
11 |
Supplement 1 |
p. A7-A8
nvt p.
|
artikel
|
| 40 |
Migraine Frequency and Health Utilities: Findings from a Multisite Survey
|
Brown, Jeffrey S.
|
|
2008
|
11 |
Supplement 1 |
p. 315-321
7 p.
|
artikel
|
| 41 |
Modeling the Potential Impact of a Prescription Drug Copayment Increase on the Adult Asthmatic Medicaid Population
|
Bae, Seung Jin
|
|
2008
|
11 |
Supplement 1 |
p. 110-118
9 p.
|
artikel
|
| 42 |
MS2 LINGUISTIC VALIDATION OF SIX QUALITY OF LIFE QUESTIONNAIRES FOR FIBROMYALGIA PATIENTS IN TWELVE LANGUAGES
|
Nadjar, A
|
|
2008
|
11 |
Supplement 1 |
p. A353-
1 p.
|
artikel
|
| 43 |
Optimal Cost-Effectiveness Decisions: The Role of the Cost-Effectiveness Acceptability Curve (CEAC), the Cost-Effectiveness Acceptability Frontier (CEAF), and the Expected Value of Perfection Information (EVPI)
|
Barton, Garry R.
|
|
2008
|
11 |
Supplement 1 |
p. 886-897
12 p.
|
artikel
|
| 44 |
Patient-Reported Outcomes and Health-Care Resource Utilization in Patients with Psoriasis Treated with Etanercept: Continuous versus Interrupted Treatment
|
Gelfand, Joel M.
|
|
2008
|
11 |
Supplement 1 |
p. 400-407
8 p.
|
artikel
|
| 45 |
PCASE6 HOW SHOULD NEWTECHNOLOGIES AND NEW DEVICES BE ASSESSED IN A HOSPITAL SYSTEM?
|
Mutnick, AH
|
|
2008
|
11 |
Supplement 1 |
p. A310-A311
nvt p.
|
artikel
|
| 46 |
PCN11 A BUDGET IMPACT ANALYSIS OF IXABEPILONE IN TREATING METASTATIC CANCER PATIENTS
|
Whillans, F
|
|
2008
|
11 |
Supplement 1 |
p. A57-
1 p.
|
artikel
|
| 47 |
PCN26 A COST-EFFECTIVENESS ANALYSIS OF XELOX AND FOLFOX-4 COMBINED WITH OR WITHOUT BEVACIZUMAB FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER IN SPAIN
|
Darba, J
|
|
2008
|
11 |
Supplement 1 |
p. A467-
1 p.
|
artikel
|
| 48 |
PCN54 A COST-UTILITY ANALYSIS OF PRIMARY PROPHYLAXIS VERSUS SECONDARY PROPHYLAXIS WITH COLONY-STIMULATING FACTOR IN ELDERLY PATIENTS WITH DIFFUSE AGGRESSIVE LYMPHOMA RECEIVING CURATIVE-INTENT CHEMOTHERAPY USING ONTARIO HEALTH ECONOMIC DATA
|
Chan, KKW
|
|
2008
|
11 |
Supplement 1 |
p. A70-A71
nvt p.
|
artikel
|
| 49 |
PCN23 COST-EFFECTIVENESS ANALYSIS OF LAPATINIB PLUS CAPECITABINE VERSUS CAPECITABINE ALONE IN THE SECOND LINE TREATMENT FOR BREAST CANCER TREATMENT
|
Ejzykowicz, F
|
|
2008
|
11 |
Supplement 1 |
p. A60-A61
nvt p.
|
artikel
|
| 50 |
PCN44 COST MINIMIZATION ANALYSIS OF ADVANCED GASTRIC CANCERTREATMENT WITH CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN POLISH SETTING
|
Kawalec, P
|
|
2008
|
11 |
Supplement 1 |
p. A473-
1 p.
|
artikel
|
| 51 |
PCN68 COST-UTILITY ANALYSIS OF DOCETAXEL VERSUS STANDARD REGIMEN IN THE NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST CANCER IN POLAND
|
Walczak, J
|
|
2008
|
11 |
Supplement 1 |
p. A481-
1 p.
|
artikel
|
| 52 |
PCN81 CROSS-CULTURAL ADAPTATION INTO SPANISH AND ITEM REDUCTION OF THE UCLA-PROSTATIC CANCER INDEX (UCLA-PCI): A SPECIFIC HEALTH RELATED QUALITY OF LIFE (HRQOL) QUESTIONNAIRE FOR PROSTATIC CANCER
|
Vera-Donoso, C
|
|
2008
|
11 |
Supplement 1 |
p. A485-
1 p.
|
artikel
|
| 53 |
PCN51 DIRECT ECONOMIC BURDEN OF HIGH RISK AND METASTATIC MELANOMA: EVIDENCE FROM THE SEER-MEDICARE LINKED DATABASE
|
Davis, KL
|
|
2008
|
11 |
Supplement 1 |
p. A69-A70
nvt p.
|
artikel
|
| 54 |
PCN41 ECONOMIC EVALUATION OF TRASTUZUMAB FOR THE ADJUVANT TREATMENT OF HER2 POSITIVE EARLY BREAST CANCER IN THE NETHERLANDS
|
Essers, BA
|
|
2008
|
11 |
Supplement 1 |
p. A472-
1 p.
|
artikel
|
| 55 |
PCN8 IMPROVED SURVIVAL OF PATIENTS WITH GLIOBLASTOMA MULTIFORME BYTEMOZOLOMIDE AS ADJUVANT THERAPY: A RETROSPECTIVE COHORT STUDY
|
Wang, TH
|
|
2008
|
11 |
Supplement 1 |
p. A56-
1 p.
|
artikel
|
| 56 |
PCN58 MEDICAL RESOURCE CONSUMPTION RELATED TO THE TREATMENT OF IRINOTECAN REFRACTORY ADVANCED COLORECTAL CANCER PATIENTS
|
Strens, D
|
|
2008
|
11 |
Supplement 1 |
p. A477-A478
nvt p.
|
artikel
|
| 57 |
PCN37 PRELIMINARY COST-CONSEQUENCE ANALYSIS OF EPIRUBICIN/CISPLATIN/5FU (ECF) COMPARED TO EPIRUBICIN/CISPLATIN/CAPECITABINE (ECX) IN PATIENTS WITH ADVANCED OESOPHAGOGASTRIC CANCER
|
Horgan, AM
|
|
2008
|
11 |
Supplement 1 |
p. A65-
1 p.
|
artikel
|
| 58 |
PCN8 QUALITY OF LIFE-ADJUSTED SURVIVAL FOR FIRST LINE TREATMENT WITH RITUXIMAB PLUS CYCLOPHOSPHAMIDE AND VINCRISTINE (CVP) VERSUS CVP ALONE FOR PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA
|
Aultman, R
|
|
2008
|
11 |
Supplement 1 |
p. A461-
1 p.
|
artikel
|
| 59 |
PCN98 RACIAL DIFFERENCES IN MEDICATION-RELATED HEALTH CARE COSTS AND SERVICE UTILIZATION IN HORMONE RECEPTOR POSITIVE PRIMARY BREAST CANCER PATIENTS
|
Bhosle, MJ
|
|
2008
|
11 |
Supplement 1 |
p. A491-
1 p.
|
artikel
|
| 60 |
PCN70 THE IMPACT OF HODGKIN S LYMPHOMA ON HEALTH RELATED QUALITY OF LIFE
|
Morlock, RJ
|
|
2008
|
11 |
Supplement 1 |
p. A75-
1 p.
|
artikel
|
| 61 |
PCN84 THE PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM CANCER PAIN ITEM BANK (PROMIS-CA PAIN)
|
Lai, JS
|
|
2008
|
11 |
Supplement 1 |
p. A486-
1 p.
|
artikel
|
| 62 |
PCN87 USE OF PHARMACOECONOMIC MESSAGES IN ONCOLOGY PROMOTIONAL MATERIALS
|
Kalpas, E
|
|
2008
|
11 |
Supplement 1 |
p. A80-A81
nvt p.
|
artikel
|
| 63 |
PCV1 A MODIFIED RXRISK-V COMORBIDITY INDEX PREDICTS ADHERENCE WITH LIPID LOWERINGTHERAPY (LLT)
|
Ghate, S
|
|
2008
|
11 |
Supplement 1 |
p. A185-
1 p.
|
artikel
|
| 64 |
PCV56 AN ECONOMIC ANALYSIS OF INDUCTION OF LABOR AND EXPECTANT MANAGEMENT INWOMEN WITH PREGNANCYINDUCED HYPERTENSION OR PREECLAMPSIA AT TERM (HYPITAT TRIAL)
|
Vijgen, SM
|
|
2008
|
11 |
Supplement 1 |
p. A398-
1 p.
|
artikel
|
| 65 |
PCV4 APPROPRIATE UTILIZATION AND COST-ANALYSIS OF ADD-ON EZETIMBE LIPID-LOWERING THERAPY AT THE VETERANS AFFAIRS SAN DIEGO HEALTH CARE SYSTEM (VASDHS)
|
Rubin, LM
|
|
2008
|
11 |
Supplement 1 |
p. A186-
1 p.
|
artikel
|
| 66 |
PCV63 BARRIERS AND MOTIVATORS ASSOCIATED WITH ADHERENCE TO ANTIHYPERTENSIVE MEDICATIONS AND BLOOD PRESSURE CONTROL AMONG AFRICAN AMERICANS FROM ALABAMA
|
Salas, M
|
|
2008
|
11 |
Supplement 1 |
p. A205-
1 p.
|
artikel
|
| 67 |
PCV24 BUDGET IMPACT OF GUIDELINE ADHERENT THERAPY IN ACUTE CORONARY SYNDROME (ACS) IN GERMANY
|
Neubauer, AS
|
|
2008
|
11 |
Supplement 1 |
p. A388-
1 p.
|
artikel
|
| 68 |
PCV28 CARDIOVASCULAR EVENT DRIVEN ECONOMIC ANALYSIS OF ROSUVASTATIN VERSUS SIMVASTATIN USING PRAGMATIC HEAD-TO-HEAD RCTSWITH SURROGATE END-POINT MEASURES
|
Farahani, P
|
|
2008
|
11 |
Supplement 1 |
p. A194-
1 p.
|
artikel
|
| 69 |
PCV111 COST-ANALYSIS OF DYSLIPOPROTEINAEMIA TREATMENTS WITHIN THE SLOVAK REPUBLIC
|
Tesar, T
|
|
2008
|
11 |
Supplement 1 |
p. A416-
1 p.
|
artikel
|
| 70 |
PCV70 COST-EFFECTIVENESS OF CLOPIDOGREL IN COMBINATION WITH ASPIRIN FOR ACUTE CORONARY SYNDROMES IN AUSTRALIA
|
Liew, D
|
|
2008
|
11 |
Supplement 1 |
p. A403-
1 p.
|
artikel
|
| 71 |
PCV39 COST-EFFECTIVENESS OF NIASPAN®VERSUS ZETIA® AS ADD-ON TREATMENTTO STATIN THERAPY IN HIGH-RISK PATIENTS
|
Sorensen, SV
|
|
2008
|
11 |
Supplement 1 |
p. A393-
1 p.
|
artikel
|
| 72 |
PCV42 COST-EFFECTIVENESS OF POPULATION-BASED 'SCREEN-AND-TREAT' STRATEGIES DIRECTED AT ALBUMINURIA
|
Boersma, C
|
|
2008
|
11 |
Supplement 1 |
p. A393-A394
nvt p.
|
artikel
|
| 73 |
PCV73 COST-EFFECTVENESS OF ENDOVASCULAR ANEURYSM REPAIR VERSUS OPEN SURGICAL REPAIR: ACUTE INFRARENAL ABDOMINAL AORTIC ANEURYSM IN AN EMERGENCY SETTING
|
Hayes, P
|
|
2008
|
11 |
Supplement 1 |
p. A404-
1 p.
|
artikel
|
| 74 |
PCV45 ECONOMIC IMPACT OF STROKE-RELATED COMORBID CONDITIONS ON THE TREATMENT OF STROKE: AN ANALYSIS OF MEDICARE BENEFICIARIES IN THE UNITED STATES
|
Lee, WC
|
|
2008
|
11 |
Supplement 1 |
p. A199-A200
nvt p.
|
artikel
|
| 75 |
PCV6 EFFECTIVENESS OF CLOPIDOGREL IN ADDITION TO ASPIRIN COMPARED TO ASPIRIN ALONE AFTER ACUTE CORONARY SYNDROME
|
Liew, D
|
|
2008
|
11 |
Supplement 1 |
p. A382-
1 p.
|
artikel
|
| 76 |
PCV14 EVALUATION OF RESISTANT HYPERTENSION IN A USUAL-CARE SETTING
|
McAdam-Marx, C
|
|
2008
|
11 |
Supplement 1 |
p. A189-A190
nvt p.
|
artikel
|
| 77 |
PCV95 IMPACT OF ADOPTION OF NEWANTIHYPERTENSIVE DRUGS ON THE HEALTH CARE UTILIZATION IN HYPERTENSIVE PATIENTS
|
Ganguli, A
|
|
2008
|
11 |
Supplement 1 |
p. A215-
1 p.
|
artikel
|
| 78 |
PCV78 INTERNATIONAL COMPARISON OF HEALTH CARE RESOURCES AND QUALITY OF LIFE IN ACUTE CORONARY SYNDROME PATIENTS IN 2007: RESULTS FROM THE ANTIPLATELETTREATMENT OBSERVATIONAL STUDY (APTOR)
|
Bakhai, A
|
|
2008
|
11 |
Supplement 1 |
p. A209-A210
nvt p.
|
artikel
|
| 79 |
PCV87 PERSISTENCE WITH AMIODARONE OR SOTALOL AND ITS IMPACT ON A TRIAL FIBRILLATION-RELATED HOSPITALIZATIONS AND CARDIOVERSIONS
|
Ishak, KJ
|
|
2008
|
11 |
Supplement 1 |
p. A408-
1 p.
|
artikel
|
| 80 |
PCV101 PROSPECTIVE STUDY TO EVALUATE THE IMPACT OF A DISEASE EDUCATION PROGRAM OF CARDIOVASCULAR RISK CONTROL IN HYPERTENSION
|
Galera, J
|
|
2008
|
11 |
Supplement 1 |
p. A413-
1 p.
|
artikel
|
| 81 |
PCV114 SEARCHING THE OPTIMAL TREATMENT MIX STRATEGY WITH A TREATMENT MIX CHART APPROACH—THE CASE OF CHOLESTEROL LOWERING IN SWEDEN
|
Martikainen, JA
|
|
2008
|
11 |
Supplement 1 |
p. A417-
1 p.
|
artikel
|
| 82 |
PCV59 THE COST AND EFFECTIVENESS OF ADHERENCE-IMPROVING INTERVENTIONS FOR LIPID-LOWERING AND ANTIHYPERTENSIVE DRUGS
|
Chapman, RH
|
|
2008
|
11 |
Supplement 1 |
p. A204-
1 p.
|
artikel
|
| 83 |
PCV92 THE HEALTH AND ECONOMIC IMPACT OF SWITCHING FROM ATORVASTATIN TO SIMVASTATIN IN THE US
|
Liew, D
|
|
2008
|
11 |
Supplement 1 |
p. A214-
1 p.
|
artikel
|
| 84 |
PDB17 AN EVALUATION OF EXPECTED WASTE OF GROWTH HORMONE PEN DEVICES AND AN ELECTRONIC GROWTH HORMONE DELIVERY DEVICE
|
Edwards, NC
|
|
2008
|
11 |
Supplement 1 |
p. A222-A223
nvt p.
|
artikel
|
| 85 |
PDB51 A RESTROSPECTIVE ANALYSIS OF MEDICATIONS ADHERENCE AND ASSOCIATED HEALTH CARE COST FOR THE DIABETIC PATIENTS
|
Jing, Y
|
|
2008
|
11 |
Supplement 1 |
p. A232-
1 p.
|
artikel
|
| 86 |
PDB34 ASSESSING DIFFERENCES IN UTILIZATION AND COSTS BETWEEN INSULIN DETEMIR (LEVEMIR) AND INSULIN GLARGINE (LANTUS) USERS
|
Borah, B
|
|
2008
|
11 |
Supplement 1 |
p. A228-
1 p.
|
artikel
|
| 87 |
PDB15 COMPARATIVE COST-UTILITY ANALYSIS OF LONG-ACTING INSULIN ANALOGUE (INSULIN DETEMIR) AND NPH INSULIN FOR THE TREATMENT OF TYPE 1 AND TYPE 2 DIABETES AND THE BUDGET IMPACT ANALYSIS OF INSULIN ANALOGUE REIMBURSEMENT IN POLAND
|
Walczak, J
|
|
2008
|
11 |
Supplement 1 |
p. A500-
1 p.
|
artikel
|
| 88 |
PDB31 COST-EFFECTIVENESS OF DETEMIRVERSUS NPH FORTYPE I DIABETES PATIENTS TREATED WITH BASAL-BOLUS THERAPY IN PORTUGAL
|
Silva, C
|
|
2008
|
11 |
Supplement 1 |
p. A227-
1 p.
|
artikel
|
| 89 |
PDB22 COST-EFFECTIVENESS OF INSULIN GLARGINE COMPARED TO INSULIN DETEMIR FOR TYPE 1 (T1DM) AND TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS IN THE CANADIAN PAYER SETTING
|
Minshall, ME
|
|
2008
|
11 |
Supplement 1 |
p. A502-
1 p.
|
artikel
|
| 90 |
PDB35 COST-UTILITY ANALYSIS OF BIPHASIC INSULIN ASPART VERSUS HUMAN INSULIN IN TYPE 2 DIABETES MELLITUS PATIENTS TREATED IN TIER III HOSPITALS IN BEIJING, CHINA: A LONGTERM OUTCOMES MODEL EVALUATION FROM THE IMPROVE OBSERVATIONAL STUDY
|
White, J
|
|
2008
|
11 |
Supplement 1 |
p. A507-
1 p.
|
artikel
|
| 91 |
PDB19 ESTIMATING THE COST EFFECTIVENESS IN THE UK OF VILDAGLIPTIN COMPARED TO PIOGLITAZONE AS ADD-ON THERAPY TO METFORMIN USING THE SHEFFIELD TYPE 2 DIABETES MODEL
|
Brennan, A
|
|
2008
|
11 |
Supplement 1 |
p. A501-
1 p.
|
artikel
|
| 92 |
PDB7 EVALUATION OF INSULIN CONTAINING ANTI-DIABETIC REGIMENS IN HIGH-RISK CARDIOVASCULAR PATIENTS WITH A PRE-TREATMENT AIC MEASUREMENT GREATER THAN 9%
|
Livengood, K
|
|
2008
|
11 |
Supplement 1 |
p. A219-
1 p.
|
artikel
|
| 93 |
PDB5 GLYCEMIC CONTROL FOLLOWING INITIATION OF INSULIN GLARGINE OR DETEMIR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS- AN ANALYSIS OF ELECTRONIC MEDICAL RECORDS
|
Levin, P
|
|
2008
|
11 |
Supplement 1 |
p. A496-A497
nvt p.
|
artikel
|
| 94 |
PDB49 HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND TREATMENT SATISFACTION (TS) IN DIABETIC PATIENTS ATTENDED IN SPANISH PRIMARY CARE CENTRES
|
De Pablos, PL
|
|
2008
|
11 |
Supplement 1 |
p. A511-A512
nvt p.
|
artikel
|
| 95 |
PDB70 IMPACT OF ANEMIA ON HOSPITALIZATION COSTS IN PATIENTS WITH DIABETES AND CHRONIC KIDNEY DISEASE
|
Laliberte, F
|
|
2008
|
11 |
Supplement 1 |
p. A238-
1 p.
|
artikel
|
| 96 |
PDB62 IMPACT OF INSURANCE PAYMENT SYSTEMS ON QUALITY OF CARE AND HEALTH CARE SERVICE UTILIZATION IN TYPE 2 DIABETES MEDICAID ENROLLEES
|
Pawaskar, MD
|
|
2008
|
11 |
Supplement 1 |
p. A516-
1 p.
|
artikel
|
| 97 |
PDB2 IMPROVED GLYCAEMIC CONTROL BY SWITCHING FROM INSULIN NPHTO INSULIN GLARGINE: A RETROSPECTIVE OBSERVATIONAL STUDY
|
Gordon, JP
|
|
2008
|
11 |
Supplement 1 |
p. A495-A496
nvt p.
|
artikel
|
| 98 |
PDB20 LONG-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR COMPARED TO NEUTRAL PROTAMINE HAGEDORN INSULIN IN PATIENTS WITH TYPE 1 DIABETES USING A BASAL-BOLUS REGIMEN IN BELGIUM, FRANCE, GERMANY, ITALY AND SPAIN
|
Gschwend, MH
|
|
2008
|
11 |
Supplement 1 |
p. A501-A502
nvt p.
|
artikel
|
| 99 |
PDB68 LONG-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR COMPARED TO NEUTRAL PROTAMINE HAGEDORN INSULIN IN PATIENTS WITH TYPE 1 DIABETES USING A BASAL-BOLUS REGIMEN IN SWEDEN
|
Valentine, WJ
|
|
2008
|
11 |
Supplement 1 |
p. A503-
1 p.
|
artikel
|
| 100 |
PDB3 SWITCHING FROM PREMIXED INSULIN TO INSULIN GLARGINE-BASED REGIMEN IMPROVES GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 1 ORTYPE 2 DIABETES: A RETROSPECTIVE PRIMARY CARE-BASED ANALYSIS
|
McEwan, P
|
|
2008
|
11 |
Supplement 1 |
p. A496-
1 p.
|
artikel
|
| 101 |
PDB1 THE IMPACT OF INSULIN DETEMIR COMPARED TO NEUTRAL PROTAMINE HAGEDORN INSULIN ON LONG-TERM DIABETES-RELATED COMPLICATIONS: A MODELING ANALYSIS IN TYPE 1 DIABETES PATIENTS IN BELGIUM, FRANCE, GERMANY, ITALY AND SPAIN
|
Gschwend, MH
|
|
2008
|
11 |
Supplement 1 |
p. A495-
1 p.
|
artikel
|
| 102 |
PDB59 TREATMENT PATTERNS AND GOAL ATTAINMENT FOR PATIENTS WITH TYPE 2 DIABETES
|
Wisloff, TF
|
|
2008
|
11 |
Supplement 1 |
p. A515-
1 p.
|
artikel
|
| 103 |
PG124 FURTHER VALIDATION OF THE GASTROINTESTINAL SHORT FORM QUESTIONNAIRE (GSFQ) IN THE SPANISH POPULATION
|
Ruiz, MA
|
|
2008
|
11 |
Supplement 1 |
p. A525-
1 p.
|
artikel
|
| 104 |
PGI5 COST-EFFECTIVENESS OF NATALIZUMAB IN CROHN'S DISEASE PATIENTS WHO HAVE FAILED ANTI-TNF ALPHA THERAPY
|
Panjabi, S
|
|
2008
|
11 |
Supplement 1 |
p. A85-
1 p.
|
artikel
|
| 105 |
PGI9 DEVELOPMENT OF A CLAIMS-BASED MARKOV MODEL FOR CROHN'S DISEASE
|
Malone, DC
|
|
2008
|
11 |
Supplement 1 |
p. A86-
1 p.
|
artikel
|
| 106 |
PGI23 PATIENT REPORTED PREVALENCE AND SEVERITY OF CONSTIPATION IN HOSPICE PATIENTS
|
Strassels, SA
|
|
2008
|
11 |
Supplement 1 |
p. A90-A91
nvt p.
|
artikel
|
| 107 |
PG110 ONCE DAILY MESALAZINE FOR MAINTAINING REMISSION IS COST-SAVING COMPARED TO TWICE DAILY MESALAZINE: AN ECONOMIC EVALUATION BASED ON THE PODIUM RANDOMISED CONTROLLED TRIAL
|
Connolly, M
|
|
2008
|
11 |
Supplement 1 |
p. A521-
1 p.
|
artikel
|
| 108 |
PG127 PSYCHOMETRIC VALIDATION OF TRANSLATION TO SPANISH OF THE REFLUX DISEASE QUESTIONNAIRE (RDQ) AND GASTROINTESTINAL IMPACT SCALE IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD)
|
Tafalla, M
|
|
2008
|
11 |
Supplement 1 |
p. A526-
1 p.
|
artikel
|
| 109 |
PHC5 COST-EFFECTIVENESS ANALYSIS OF THROMBOPROPHYLACTIC STRATEGIES OVER ONEYEAR AFTERTOTAL KNEE REPLACEMENT IN VETERAN PATIENTS
|
Campbell, HM
|
|
2008
|
11 |
Supplement 1 |
p. A242-A243
nvt p.
|
artikel
|
| 110 |
PHC8 COST-EFFECTIVENESS COMPARISON OF TENSION-FREE MESH REPAIR VS. TENSION SUTURE REPAIR METHODS OF INGUINAL HERNIA IN SLOVAKIA
|
Plisko, R
|
|
2008
|
11 |
Supplement 1 |
p. A243-A244
nvt p.
|
artikel
|
| 111 |
PHC1 TREATMENT OF DISCOGENIC LOW BACK PAIN WITH INTRADISCAL ELECTROTHERMAL THERAPY [IDET], A MINIMALLY INVASIVE, LOW COST ALTERNATIVE TO OPEN SURGERY: A PROSPECTIVE 24-MONTH OUTCOMES STUDY IN 50 CONSECUTIVE PATIENTS
|
Assietti, R
|
|
2008
|
11 |
Supplement 1 |
p. A531-
1 p.
|
artikel
|
| 112 |
PHP8 ADVERSE DRUG REACTIONS IN GERMANY: COST ANALYSIS OF INTERNAL MEDICINE HOSPITALIZATIONS
|
Rottenkolber, D
|
|
2008
|
11 |
Supplement 1 |
p. A364-A365
nvt p.
|
artikel
|
| 113 |
PHP76 ALBERTA'S HEALTH SYSTEM PERFORMANCES BALANCED SCORECARD STUDY
|
Thanh, NX
|
|
2008
|
11 |
Supplement 1 |
p. A52-
1 p.
|
artikel
|
| 114 |
PHP23 CHARACTERISTICS OF UTILIZATION OF PRIMARY CARE OF GENERAL PRACTITIONERS IN COUNTY BARANYA IN HUNGARY
|
Sebestyen, A
|
|
2008
|
11 |
Supplement 1 |
p. A369-
1 p.
|
artikel
|
| 115 |
PHP45 COMMON DRUG REVIEW (CDR) RECOMMENDATIONS: DOES COST-EFFECTIVENESS MATTER?
|
Rocchi, A
|
|
2008
|
11 |
Supplement 1 |
p. A42-
1 p.
|
artikel
|
| 116 |
PHP13 CONTROLLED SUBSTANCEWASTE IN HOME HOSPICE SETTINGS
|
Maxwell, T
|
|
2008
|
11 |
Supplement 1 |
p. A32-A33
nvt p.
|
artikel
|
| 117 |
PHP10 CREATION OF A RISK RATING SYSTEMTO COMMUNICATE DRUG SAFETY INFORMATIONTO CONSUMERS
|
Cascade, EF
|
|
2008
|
11 |
Supplement 1 |
p. A31-A32
nvt p.
|
artikel
|
| 118 |
PHP59 DRUG THERAPY PROBLEMS: DOES PHARMACIST'S INTERVENTION SAVE COST?
|
Udezi, WA
|
|
2008
|
11 |
Supplement 1 |
p. A46-A47
nvt p.
|
artikel
|
| 119 |
PHP42 EVALUATION OF THE AFTERNOON OUTPATIENT CLINICS OPERATION AT THE UNIVERSITY HOSPITAL IN LARISA
|
Geitona, M
|
|
2008
|
11 |
Supplement 1 |
p. A375-
1 p.
|
artikel
|
| 120 |
PHP5 HEALTH LITERACY—AN ECONOMIC PERSPECTIVE: A SYSTEMATIC REVIEW
|
Eichler, K
|
|
2008
|
11 |
Supplement 1 |
p. A363-A364
nvt p.
|
artikel
|
| 121 |
PHP62 HOW EVIDENCE-BASED AND TIMELY ARE MEDICARE COVERAGE DECISIONS FOR NEWTECHNOLOGIES: AN EMPIRICAL ANALYSIS, 1999-2007
|
Kamae, M
|
|
2008
|
11 |
Supplement 1 |
p. A47-A48
nvt p.
|
artikel
|
| 122 |
PHP56 IMPACT OF ICU SEDATION PRACTICE ON PATIENT MORBIDITY, COST AND HOSPITAL RESOURCE USE: A SYSTEMATIC REVIEW
|
Jackson, D
|
|
2008
|
11 |
Supplement 1 |
p. A379-
1 p.
|
artikel
|
| 123 |
PHP39 LINKING HOSPITAL ADMISSION DATA INTO PRIMARY CARE RECORDS WITHIN THE GENERAL PRACTICE RESEARCH DATABASE
|
Williams, TJ
|
|
2008
|
11 |
Supplement 1 |
p. A374-
1 p.
|
artikel
|
| 124 |
PHP28 THE PROCESS OF UPDATINGTHE NATIONAL LIST OF HEALTH SERVICES IN ISRAEL: IS IT LEGITIMATE? IS IT FAIR?
|
Greenberg, D
|
|
2008
|
11 |
Supplement 1 |
p. A37-
1 p.
|
artikel
|
| 125 |
PIH23 MEDICATION COSTS IN ELDERLY PATIENTS
|
Mendes, Z
|
|
2008
|
11 |
Supplement 1 |
p. A427-
1 p.
|
artikel
|
| 126 |
PIH6 SYSTEMATIC REVIEW OF ECONOMIC EVALUATION STUDIES IN OBSTETRICS, GYNAECOLOGY AND REPRODUCTIVE MEDICINE
|
Vijgen, SM
|
|
2008
|
11 |
Supplement 1 |
p. A422-
1 p.
|
artikel
|
| 127 |
PIH10 THE COST-EFFECTIVENESS OF ROUTINE SCREENING FOR VASA PREVIA AT 18-20 WEEKS GESTATION IN ONTARIO
|
Cipriano, LE
|
|
2008
|
11 |
Supplement 1 |
p. A248-
1 p.
|
artikel
|
| 128 |
PIH25 VARIATIONS IN ANTIPSYCHOTIC THERAPY AND SHORT-TERM MORTALITY ACROSS LONG-TERM CARE HOMES
|
Bronskill, SE
|
|
2008
|
11 |
Supplement 1 |
p. A253-
1 p.
|
artikel
|
| 129 |
PIN37 AN EXAMINATION OF THE CORRELATION BETWEEN QUALITY OF PATIENT CARE AND PATIENT RACE OR SOCIAL CLASS IN INPATIENT APPENDICITIS CASES
|
Cerrito, PB
|
|
2008
|
11 |
Supplement 1 |
p. A104-
1 p.
|
artikel
|
| 130 |
PIN51 A PICTURE OF DEMOGRAPHIC DISPARITIES IN THE RECEIPT OF ANTIRETROVIRAL THERAPY AMONG HIV PATIENTS IN THE 2000-2005 NATIONAL AMBULATORY MEDICAL CARE SURVEYS (NAMCS)
|
Oramasionwu, CU
|
|
2008
|
11 |
Supplement 1 |
p. A108-
1 p.
|
artikel
|
| 131 |
PIN16 COST-EFFECTIVENESS OF A PROPHYLACTIC HUMAN PAPILLOMA VIRUS 16/18 VACCINE FOR 12-YEAR-OLD DUTCH GIRLS
|
Westra, TA
|
|
2008
|
11 |
Supplement 1 |
p. A433-
1 p.
|
artikel
|
| 132 |
PIN43 DIFFERENCE IN HEALTH CARE UTILIZATION IN EUROPE BETWEENTREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C AND PATIENTSWHO FAILED PRIOR THERAPY
|
Zhang, H
|
|
2008
|
11 |
Supplement 1 |
p. A442-
1 p.
|
artikel
|
| 133 |
PIN21 ECONOMICAL EVALUATION OF ETRAVIRINE IN TREATMENT-EXPERIENCED HIV-1-INFECTED PATIENTS BASED ON DUET TRIALS
|
Avxentyeva, M
|
|
2008
|
11 |
Supplement 1 |
p. A434-A435
nvt p.
|
artikel
|
| 134 |
PIN13 ECONOMIC ANALYSIS OF MICAFUNGIN VERSUS LIPOSOMAL AMPHOTERICIN B FOR TREATMENT OF CANDIDAEMIA AND INVASIVE CANDIDIASIS IN ITALY
|
Viale, P
|
|
2008
|
11 |
Supplement 1 |
p. A432-
1 p.
|
artikel
|
| 135 |
PIN29 EFFECTIVENESS AND COST-EFFECTIVENESS OF HEPATITIS C SCREENING—A SYSTEMATIC REVIEW
|
Sroczynski, G
|
|
2008
|
11 |
Supplement 1 |
p. A437-A438
nvt p.
|
artikel
|
| 136 |
PIN46 HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS WITH VENOUS LEG ULCER
|
Chen, S
|
|
2008
|
11 |
Supplement 1 |
p. A443-
1 p.
|
artikel
|
| 137 |
PIN5 INTEREST OF MULTI-CRITERIA MODELING APPROACH IN ASSESSMENT OF YELLOW FEVER EPIDEMIC RISK
|
Beresniak, A
|
|
2008
|
11 |
Supplement 1 |
p. A93-A94
nvt p.
|
artikel
|
| 138 |
PIN23 PHARMACOECONOMIC ANALYSIS OF ANTIFUNGAL AGENTS FOR THE MANAGEMENT OF NON NEUTROPENIC PATIENTS WITH INVASIVE CANDIDIASIS ATTHE SOCIAL SECURITY MEXICAN INSTITUTE (IMSS)
|
Contreras-Hernandez, I
|
|
2008
|
11 |
Supplement 1 |
p. A99-
1 p.
|
artikel
|
| 139 |
PIN20 PHARMACOECONOMICS OF CHRONIC HEPATITIS BAND HEPATITIS C
|
Freiberga, M
|
|
2008
|
11 |
Supplement 1 |
p. A98-
1 p.
|
artikel
|
| 140 |
PMC5 A MISSING DATATHRESHOLD AS APPLIED TO HEALTH OUTCOMES DATA: DIFFERENTIAL IMPLICATIONS FOR COST-UTILITY ANALYSIS BY DIAGNOSIS
|
Bush, S
|
|
2008
|
11 |
Supplement 1 |
p. A560-
1 p.
|
artikel
|
| 141 |
PMC26 APPLICATION OFTHE FRAMEWORK FOR EVALUATING COMPLEX INTERVENTIONS TO CLUSTER RANDOMIZED TRIALS FOR THE EVALUATION OF DISEASE MANAGEMENT PROGRAMS
|
Marchisio, S
|
|
2008
|
11 |
Supplement 1 |
p. A177-
1 p.
|
artikel
|
| 142 |
PMC37 CHALLENGES OF TRANSLATING AND LINGUISTICALLY VALIDATING PRO MEASURES INTO SLAVIC LANGUAGES
|
Merry, R
|
|
2008
|
11 |
Supplement 1 |
p. A570-
1 p.
|
artikel
|
| 143 |
PMC19 COST-EFFECTIVENESS ANALYSES OF BEHAVIORAL INTERVENTIONS: TOWARDS A MORE REALISTIC COST-EFFECTIVENESS RATIO BY INCLUDING INTERMEDIATE OUTCOME MEASURES
|
Prenger, R
|
|
2008
|
11 |
Supplement 1 |
p. A565-
1 p.
|
artikel
|
| 144 |
PMC41 MAPPING SF-12 TO EUROQOL EQ-5D PREFERENCE SCORES IN THE SPANISH-SPEAKING HISPANIC COMMUNITY IN THE UNITED STATES
|
Zarate, V
|
|
2008
|
11 |
Supplement 1 |
p. A181-
1 p.
|
artikel
|
| 145 |
PMC23 PREDICTION MODELS FOR TRANSITIONS IN THE ELDERLY USING ADMINISTRATIVE CLAIMS
|
Rapp, T
|
|
2008
|
11 |
Supplement 1 |
p. A176-
1 p.
|
artikel
|
| 146 |
PMC22 THE IMPACT OF COMORBIDITY BURDEN AND AGE ON PREFERENCE-BASED HRQL IN THE UNITED STATES
|
Sullivan, PW
|
|
2008
|
11 |
Supplement 1 |
p. A566-
1 p.
|
artikel
|
| 147 |
PMC54 THE RIGOUR, FLEXIBILITY AND EASE OF IMPLEMENTATION OF SYSTEMATIC SEARCH STRATEGIES—DOWE NEED AN INDUSTRY STANDARD METHODOLOGY?
|
Reaney, MD
|
|
2008
|
11 |
Supplement 1 |
p. A575-A576
nvt p.
|
artikel
|
| 148 |
PMC51 UTILITIES OF THE EQ-5D:TRANSFERABLE OR NOT? INFLUENCE OF THE NATIONAL VALUE SETS OF THE EQ-5D ON THE INCREMENTAL UTILITIES OF TWO HEALTH STATES
|
Knies, S
|
|
2008
|
11 |
Supplement 1 |
p. A575-
1 p.
|
artikel
|
| 149 |
PMC9 30 YEARS OF COST-EFFECTIVENESS ANALYSES:A BIBLIOMETRIC REVIEW OF ARTICLES PUBLISHED IN THE ECONOMIC AND MEDICAL LITERATURE: 1976–2005
|
Greenberg, D
|
|
2008
|
11 |
Supplement 1 |
p. A172-
1 p.
|
artikel
|
| 150 |
PMH32 A GPRD STUDY OF HEALTH CARE COST ASSOCIATED WITH DIFFERENT FIRST-LINE ANTIDEPRESSANT TREATMENTS IN SEVERE DEPRESSION
|
Wade, AG
|
|
2008
|
11 |
Supplement 1 |
p. A589-
1 p.
|
artikel
|
| 151 |
PMH2 BENCHMARKING SCHIZOPHRENIA WITH A FOCUS ON PHARMACOTHERAPYAND METABOLIC SYNDROME
|
Prescott, J
|
|
2008
|
11 |
Supplement 1 |
p. A109-
1 p.
|
artikel
|
| 152 |
PMH35 COST-EFFECTIVENESS OF ORALLY DISSOLVING OLANZAPINE TABLETS IN THE TREATMENT OF SCHIZOPHRENIA IN THE USA
|
Ascher-Svanum, H
|
|
2008
|
11 |
Supplement 1 |
p. A119-
1 p.
|
artikel
|
| 153 |
PMH2 DIRECT AND INDIRECT TREATMENT EFFECTS ON SLEEP DISTURBANCE IN GENERALIZED ANXIETY DISORDER: A STATISTICAL MEDIATION MODEL ANALYSIS
|
Bollu, V
|
|
2008
|
11 |
Supplement 1 |
p. A579-
1 p.
|
artikel
|
| 154 |
PMH78 EFFECTS OF DIRECT-TO-CONSUMER ADVERTISING AND DETAILING SPENDING ON ANTIDEPRESSANT SWITCH AND TREATMENT COMPLETION
|
Chen, SY
|
|
2008
|
11 |
Supplement 1 |
p. A133-
1 p.
|
artikel
|
| 155 |
PMH60 HEALTH STATUS ANDWORK-RELATED OUTCOMES OF PATIENTS WITH ANXIETY DISORDERS AND DEPRESSION
|
Erickson, S
|
|
2008
|
11 |
Supplement 1 |
p. A127-A128
nvt p.
|
artikel
|
| 156 |
PMH49 INTERNATIONAL INVESTIGATION INTO DEPRESSION BASED ON THE STRUCTURED INTERVIEW GUIDE FOR THE HAMILTON DEPRESSION RATING SCALE (SIGH-D) AND THE CLINICIAN RATED INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY (IDS-C)
|
Caire, P
|
|
2008
|
11 |
Supplement 1 |
p. A595-
1 p.
|
artikel
|
| 157 |
PMH50 MEDICATION ADHERENCE, ETHNICITY, ANDTHE INFLUENCE OF MULTIPLE PSYCHOSOCIAL AND FINANCIAL BARRIERS IN VETERANS WITH BIPOLAR DISORDER
|
Zeber, JE
|
|
2008
|
11 |
Supplement 1 |
p. A124-
1 p.
|
artikel
|
| 158 |
PMH17 METABOLIC MONITORING AMONG SCHIZOPHRENIA PATIENTS INITIATED ON ATYPICAL ANTIPSYCHOTICS IN THE VETERAN HEALTH ADMINISTRATION
|
Shi, L
|
|
2008
|
11 |
Supplement 1 |
p. A114-
1 p.
|
artikel
|
| 159 |
PMH46 PATIENT PREFERENCES IN ADHD—DISCRETE CHOICE EXPERIMENT
|
Mühlbacher, AC
|
|
2008
|
11 |
Supplement 1 |
p. A594-
1 p.
|
artikel
|
| 160 |
PMH63 PATIENT REPORTED MEASURES AS QUALITY ASSURANCE TOOLS IN CNS CLINICAL TRIALS
|
Daniel, DG
|
|
2008
|
11 |
Supplement 1 |
p. A128-A129
nvt p.
|
artikel
|
| 161 |
PMH16 THE COST-EFFECTIVENESS OF PALIPERIDONE ER IN ACUTE PHASE OF SCHIZOPHRENIA IN TURKEY
|
Kanbur, B
|
|
2008
|
11 |
Supplement 1 |
p. A584-
1 p.
|
artikel
|
| 162 |
PMS37 ASSESSING THE VALIDITY AND RELIABILITY OF A SIMPLE ACTIVITY PARTICIPATION MEASURE FOR RHEUMATOID ARTHRITIS CLINICAL TRIALS
|
Li, T
|
|
2008
|
11 |
Supplement 1 |
p. A266-
1 p.
|
artikel
|
| 163 |
PMS6 BUDGET IMPACT ANALYSIS OFABATACEPT INCLUSION FOR MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN THE BRAZILIAN PUBLIC SYSTEM
|
Alves, MR
|
|
2008
|
11 |
Supplement 1 |
p. A256-
1 p.
|
artikel
|
| 164 |
PMS1 COGNITIVE IMPAIRMENT IN PATIENTS WITH FIBROMYALGIA SYNDROME AS ASSESSED BY THE MINIMENTAL STATE EXAMINATION
|
Rodríguez-Andreu, J
|
|
2008
|
11 |
Supplement 1 |
p. A536-
1 p.
|
artikel
|
| 165 |
PMS4 COST-EFFECTIVENESS ANALYSIS OF LEFLUNOMIDE AS A TREATMENT FOR RHEUMATOID ARTHRITIS IN MEXICO
|
Carlos-Rivera, F
|
|
2008
|
11 |
Supplement 1 |
p. A537-
1 p.
|
artikel
|
| 166 |
PMS9 COST-EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)AND INADEQUATE RESPONSE TO METHOTREXATE (MTX) ORTUMOR NECROSIS FACTOR-ALPHA INHIBITORS (ANTI-TNFS):A CANADIAN PERSPECTIVE
|
Maier-Moldovan, M
|
|
2008
|
11 |
Supplement 1 |
p. A257-
1 p.
|
artikel
|
| 167 |
PMS18 COSTS OF TREATMENT OF RHEUMATOID ARTHRITIS WITH BIOLOGICAL DRUGS
|
Rasmussen, C
|
|
2008
|
11 |
Supplement 1 |
p. A541-
1 p.
|
artikel
|
| 168 |
PMS43 GOLIMUMAB, A HUMAN ANTI-TNF-ALPHA MONOCLONAL ANTIBODY, SIGNIFICANTLY REDUCES TIME LOST FROM WORK FOR PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED RESULTS FROMTHREE PHASE 3 STUDIES
|
Buchanan, J
|
|
2008
|
11 |
Supplement 1 |
p. A550-
1 p.
|
artikel
|
| 169 |
PMS23 MODELLING OF BURDEN OF FEMORAL NECK FRACTURE IN 2007 FROM PURCHASER'S POINT OF VIEW
|
Sebestyén, A
|
|
2008
|
11 |
Supplement 1 |
p. A261-
1 p.
|
artikel
|
| 170 |
PMS40 ORALVS INJECTABLE TREATMENTS: PATIENT PREFERENCE IN BRAZILIAN PATIENTS
|
Boscatti, FHG
|
|
2008
|
11 |
Supplement 1 |
p. A267-
1 p.
|
artikel
|
| 171 |
PMS63 PATIENT REPORTED OUTCOMES OF DIFFERENT SURGICAL PROCEDURES IN PATIENTS WITH CARTILAGE DEFECTS OF THE KNEE AFTER 1 TO 5YEARS
|
Brüggenjürgen, B
|
|
2008
|
11 |
Supplement 1 |
p. A556-A557
nvt p.
|
artikel
|
| 172 |
PMS60 QUALITATIVE STEPS FOR THE DEVELOPMENT OF A QUESTIONNAIRE ASSESSING THE BURDEN OF FIBROMYALGIA ON PATIENTS' DAILY LIVES
|
Arnould, B
|
|
2008
|
11 |
Supplement 1 |
p. A555-A556
nvt p.
|
artikel
|
| 173 |
PMS57 VALIDITY AND RESPONSIVENESS OF THE WORK PRODUCTIVITY SURVEY: A NOVEL DISEASE-SPECIFIC INSTRUMENT ASSESSINGWORK PRODUCTIVITY WITHIN AND OUTSIDE THE HOME IN SUBJECTS WITH RHEUMATOID ARTHRITIS
|
Osterhaus, J
|
|
2008
|
11 |
Supplement 1 |
p. A554-A555
nvt p.
|
artikel
|
| 174 |
PND2 HUNTINGTON'S DISEASE: WHERE HAVEWE BEEN?
|
Samuels, E
|
|
2008
|
11 |
Supplement 1 |
p. A600-
1 p.
|
artikel
|
| 175 |
PND20 MEASURING THE IMPACT OF NARCOLEPSY ON QUALITY OF LIFE: A SYSTEMATIC REVIEW
|
Khagram, L
|
|
2008
|
11 |
Supplement 1 |
p. A605-A606
nvt p.
|
artikel
|
| 176 |
PND8 MEDICAL COSTS ASSOCIATED WITHTREATMENT CHANGE IN MULTIPLE SCLEROSIS
|
Nordstrom, B
|
|
2008
|
11 |
Supplement 1 |
p. A138-A139
nvt p.
|
artikel
|
| 177 |
PND36 OBSERVED DIFFERENCES BETWEEN DAILY DIARY AND WEEKLY REPORT OF CYSTIC FIBROSIS SYMPTOMS
|
Bennett, AV
|
|
2008
|
11 |
Supplement 1 |
p. A148-
1 p.
|
artikel
|
| 178 |
PND17 ONE-YEAR EXPENSES FOR THE PHARMACOLOGICAL MANAGEMENT OF EPILEPSY WITHIN OUTPATIENT SETTING OF MONTENEGRO: RATIONAL OR NOT?
|
Duborija-Kovacevic, N
|
|
2008
|
11 |
Supplement 1 |
p. A604-A605
nvt p.
|
artikel
|
| 179 |
PND39 PATIENT- AND PHYSICIAN-ASSESSED FUNCTIONAL DISABILITY IN PATIENTS TREATED WITH BOTULINUM TOXIN TYPE A FOR CERVICAL DYSTONIA
|
Bramley, T
|
|
2008
|
11 |
Supplement 1 |
p. A148-A149
nvt p.
|
artikel
|
| 180 |
PND5 SUBSTANCE ABUSE AMONG PATIENTS DIAGNOSED WITH INSOMNIA
|
Boulanger, L
|
|
2008
|
11 |
Supplement 1 |
p. A137-A138
nvt p.
|
artikel
|
| 181 |
PND22 THE COST OF DISABILITY AND MEDICALLY-RELATED ABSENTEEISM AMONG EMPLOYEES WITH MULTIPLE SCLEROSIS
|
Birnbaum, HG
|
|
2008
|
11 |
Supplement 1 |
p. A143-
1 p.
|
artikel
|
| 182 |
Probabilistic Cost-Effectiveness Modeling of Different Breast Cancer Screening Policies in Slovenia
|
Rojnik, Klemen
|
|
2008
|
11 |
Supplement 1 |
p. 139-148
10 p.
|
artikel
|
| 183 |
PRS42 ASTHMA DISEASE BURDEN, EVIDENTIARY REQUIREMENTS, AND FORMULARY CONSIDERATIONS AMONG MANAGED CARE AND EMPLOYER DECISION MAKERS REGARDING INHALED CORTICOSTEROIDS (ICS)
|
O'Day, K
|
|
2008
|
11 |
Supplement 1 |
p. A282-
1 p.
|
artikel
|
| 184 |
PRS35 CHALLENGING ASTHMA MANAGEMENT WITH THE USE OF LABA/ICS COMBINATION VIA ATURBUHALER DEVICE, BOTH FOR MAINTENANCE AS WELL AS RELIEF, AND IT'S INFLUENCE ON ASTHMA CONTROL AND PATIENTS' WELL-BEING IN GREECE
|
Rasidakis, A
|
|
2008
|
11 |
Supplement 1 |
p. A456-A457
nvt p.
|
artikel
|
| 185 |
PRS18 DIFFERENCES IN TREATMENT COSTS AND RESOURCE UTILIZATION AMONG COPD PATIENTS TREATED WITH ALBUTEROL MDI OR LEVALBUTEROL MDI
|
Ohsfeldt, R
|
|
2008
|
11 |
Supplement 1 |
p. A451-
1 p.
|
artikel
|
| 186 |
PRS8 HEALTH ECONOMICS OF ASTHMAASSESSING THE VALUE OF ASTHMA INTERVENTIONS
|
Spackman, DE
|
|
2008
|
11 |
Supplement 1 |
p. A271-
1 p.
|
artikel
|
| 187 |
PRS2 RELATIVE EFFECTIVENESS OF INHALED CORTICOSTEROIDS AND LEUKOTRIENE-RECEPTOR ANTAGONISTS TO PREVENT MODERATE-TO-SEVERE EXACERBATIONS AMONG ASTHMATIC CHILDREN
|
Blais, L
|
|
2008
|
11 |
Supplement 1 |
p. A446-
1 p.
|
artikel
|
| 188 |
PRS32 SYMPTOMS AND IMPACT OF SYMPTOMS AS REPORTED BY ASTHMA PATIENTS
|
Williams, AE
|
|
2008
|
11 |
Supplement 1 |
p. A455-A456
nvt p.
|
artikel
|
| 189 |
PRS39 THE IMPACT OF FORMULARY POLICIES ON THE USE OF MEDICATION FOR RESPIRATORY DISEASE: A COMPARISON OF DRUG UTILIZATION IN THE PROVINCES OF ONTARIO AND ALBERTA
|
Pilla, J
|
|
2008
|
11 |
Supplement 1 |
p. A281-
1 p.
|
artikel
|
| 190 |
PRS25 VALIDATION OF CLAIMS-BASED PERSISTENT ASTHMA SEVERITY CLASSIFICATION
|
Yu, AP
|
|
2008
|
11 |
Supplement 1 |
p. A277-
1 p.
|
artikel
|
| 191 |
PSS21 ADMINISTRATIVE PREVALENCE OF PSORIASIS IN GERMANY
|
Schlander, M
|
|
2008
|
11 |
Supplement 1 |
p. A615-A616
nvt p.
|
artikel
|
| 192 |
PSS19 A PHARMACOECONOMIC EVALUATION OF PEGAPTANIB FOR THE MANAGEMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) IN MEXICO
|
Vega-Hernández, GY
|
|
2008
|
11 |
Supplement 1 |
p. A290-
1 p.
|
artikel
|
| 193 |
PSS36 COMPARISON OF THE QUALITY OF LIFE IMPACT OF PERIPHERAL VISION LOSS VERSUS CENTRAL VISION LOSS
|
Walt, JG
|
|
2008
|
11 |
Supplement 1 |
p. A295-
1 p.
|
artikel
|
| 194 |
PSS35 COST UTILITY OF BILATERAL COCHLEAR IMPLANT
|
Callejo, D
|
|
2008
|
11 |
Supplement 1 |
p. A620-
1 p.
|
artikel
|
| 195 |
PSS33 INTERNATIONAL DEVELOPMENT OF THE FIRST QUALITY OF LIFE INSTRUMENT SPECIFIC TO COSMETOLOGY AND PHYSICAL APPEARANCE:THE BEAUTYQOL INITIATIVE
|
Beresniak, A
|
|
2008
|
11 |
Supplement 1 |
p. A294-A295
nvt p.
|
artikel
|
| 196 |
PSS5 MEDICAL COST OF GLAUCOMA IN SWEDEN
|
Strom, O
|
|
2008
|
11 |
Supplement 1 |
p. A285-A286
nvt p.
|
artikel
|
| 197 |
PSS38 RELATION BETWEEN SELF REPORTED GLAUCOMA SYMPTOMS AND COMPLIANCE
|
Ruiz, MA
|
|
2008
|
11 |
Supplement 1 |
p. A621-
1 p.
|
artikel
|
| 198 |
PSS52 SCORING AND PSYCHOMETRIC PROPERTIES OF THE EYE-DROP SATISFACTION QUESTIONNAIRE (EDSQ)
|
Regnault, A
|
|
2008
|
11 |
Supplement 1 |
p. A625-
1 p.
|
artikel
|
| 199 |
PSS50 TRENDS IN MEDICATION PRESCRIBING FOR ACNE IN THE UNITED STATES ACCORDING TO PATIENT AGE
|
Uhas, AA
|
|
2008
|
11 |
Supplement 1 |
p. A300-
1 p.
|
artikel
|
| 200 |
PSS3 VISION WITH RESTOR®, ARRAY® SA40 AND A MONOFOCAL INTRA-OCULAR LENS (IOL) AFTER CATARACT SURGERY
|
De vries, N
|
|
2008
|
11 |
Supplement 1 |
p. A610-
1 p.
|
artikel
|
| 201 |
PSY9 BUDGET IMPACT OF THE USE OF OROS® HYDROMORPHONE ONCE DAILY IN SEVERE CHRONIC PAIN PATIENTS IN THE GERMAN HEALTH CARE SYSTEM
|
Fleischmann, J
|
|
2008
|
11 |
Supplement 1 |
p. A631-
1 p.
|
artikel
|
| 202 |
Psychometric Equivalence of the OAB-q in Danish, German, Polish, Swedish, and Turkish
|
Coyne, Karin S.
|
|
2008
|
11 |
Supplement 1 |
p. 1096-1101
6 p.
|
artikel
|
| 203 |
Psychometric Validation of the Cancer Therapy Satisfaction Questionnaire
|
Trask, Peter C.
|
|
2008
|
11 |
Supplement 1 |
p. 669-679
11 p.
|
artikel
|
| 204 |
PSY32 COST-UTILITY STUDY OF RECOMBINANT FACTORVIII IN THE TREATMENT OF HEMOPHILIA A IN MEXICO
|
Soria-Cedillo, IF
|
|
2008
|
11 |
Supplement 1 |
p. A162-
1 p.
|
artikel
|
| 205 |
PSY5 CROSS-CULTURAL COMPARISONS OFTHE OVERWEIGHT/OBESE POPULATION IN THE US AND EUROPE
|
Annunziata, K
|
|
2008
|
11 |
Supplement 1 |
p. A153-
1 p.
|
artikel
|
| 206 |
PSY42 E-DIARY COMPLIANCE IN ACUTE PAIN STUDIES
|
Marino, B
|
|
2008
|
11 |
Supplement 1 |
p. A642-
1 p.
|
artikel
|
| 207 |
PSY39 IMPACT OF HIGHWAIST CIRCUMFERENCE ON PRODUCTIVITY IN US AND GERMAN OVERWEIGHT/OBESE SUBJECTS
|
Caterson, I
|
|
2008
|
11 |
Supplement 1 |
p. A641-
1 p.
|
artikel
|
| 208 |
PSY47 IMPACT OF NIGHTTIME PAIN ON SLEEP QUALITY IN PATIENTS WITH CHRONIC PAINFUL CONDITIONS
|
Chaudhari, PK
|
|
2008
|
11 |
Supplement 1 |
p. A166-
1 p.
|
artikel
|
| 209 |
PSY50 PHYSICIANS' INTENTIONS TO MEASURE BODY MASS INDEX IN CHILDREN AND ADOLESCENTS:ATHEORY OF REASONED ACTION MODEL
|
Khanna, R
|
|
2008
|
11 |
Supplement 1 |
p. A167-
1 p.
|
artikel
|
| 210 |
PSY6 PREDICTING FACTORS FOR METABOLIC SYNDROME FOR US ADOLESCENTS AGE 12–17
|
Sias, S
|
|
2008
|
11 |
Supplement 1 |
p. A630-
1 p.
|
artikel
|
| 211 |
PSY52 QUALITY OF LIFE IN RUSSIAN PATIENTS WITH HEREDITARY COAGULOPATHIES. INTERMEDIATE RESULTS
|
Vorobyev, P
|
|
2008
|
11 |
Supplement 1 |
p. A645-A646
nvt p.
|
artikel
|
| 212 |
PSY25 SYSTEMATIC REVIEW OF THE COST OF ILLNESS OF SYSTEMIC LUPUS ERYTHEMATOSUS
|
Richard, L
|
|
2008
|
11 |
Supplement 1 |
p. A636-
1 p.
|
artikel
|
| 213 |
PUK17 ECONOMIC EVALUATION OF SEVELAMER VERSUS CALCIUM-BASED PHOSPHATE BINDERS IN PATIENTS ON DIALYSIS IN THE UNITED KINGDOM SETTING
|
Wex, J
|
|
2008
|
11 |
Supplement 1 |
p. A305-
1 p.
|
artikel
|
| 214 |
PUK2 IN GREECE, INCREASING THE UTILIZATION OF PERITONEAL DIALYSIS THERAPY MAY REDUCE OVERALL DIALYSIS EXPENDITURES
|
Walker, DR
|
|
2008
|
11 |
Supplement 1 |
p. A650-
1 p.
|
artikel
|
| 215 |
PUK14 INPATIENT COSTS AND CLINICAL OUTCOMES OF S. AUREUS BLOODSTREAM AND NON-BLOODSTREAM INFECTION IN PATIENTS WITH END-STAGE RENAL DISEASE: FINDINGS FROM A MULTI-CENTER TRIAL
|
Li, Y
|
|
2008
|
11 |
Supplement 1 |
p. A304-
1 p.
|
artikel
|
| 216 |
PUK19 PSYCHOMETRIC EVALUATION OF THE KHQ IN TEN LANGUAGES
|
Coyne, KS
|
|
2008
|
11 |
Supplement 1 |
p. A655-A656
nvt p.
|
artikel
|
| 217 |
QL9 DEVELOPMENT AND VALIDATION OF AN ELETRONIC VERSION OF THE HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX (HAQ-DI)
|
Tiplady, B
|
|
2008
|
11 |
Supplement 1 |
p. A354-
1 p.
|
artikel
|
| 218 |
QL7 INTERPRETING SCORES ON THREE COPD PATIENT-REPORTED OUTCOME MEASURES
|
McKenna, SP
|
|
2008
|
11 |
Supplement 1 |
p. A348-
1 p.
|
artikel
|
| 219 |
Quantifying the Decrement in Utility from Perceived Side Effects of Combination Antiretroviral Therapies in Patients with HIV
|
Braithwaite, R. Scott
|
|
2008
|
11 |
Supplement 1 |
p. 975-979
5 p.
|
artikel
|
| 220 |
Reliability of Two Instruments for Critical Assessment of Economic Evaluations
|
Au, Flora
|
|
2008
|
11 |
Supplement 1 |
p. 435-439
5 p.
|
artikel
|
| 221 |
Self-Reported Adverse Events after Groin Hernia Repair, A Study Based on a National Register
|
Fränneby, Ulf
|
|
2008
|
11 |
Supplement 1 |
p. 927-932
6 p.
|
artikel
|
| 222 |
Service Utilization and Health-Care Costs in the Advanced Elderly
|
Heinrich, Sven
|
|
2008
|
11 |
Supplement 1 |
p. 611-620
10 p.
|
artikel
|
| 223 |
The Direct Medical Costs of Undiagnosed Chronic Obstructive Pulmonary Disease
|
Mapel, Douglas W.
|
|
2008
|
11 |
Supplement 1 |
p. 628-636
9 p.
|
artikel
|
| 224 |
The Impact of Atypical Antipsychotic Medications on the Use of Health Care by Patients with Schizophrenia
|
Chen, Lei
|
|
2008
|
11 |
Supplement 1 |
p. 34-43
10 p.
|
artikel
|
| 225 |
The Impact of Body Weight on Patient Utilities with or without Type 2 Diabetes: A Review of the Medical Literature
|
Dennett, Susan L.
|
|
2008
|
11 |
Supplement 1 |
p. 478-486
9 p.
|
artikel
|
| 226 |
Time and Expected Value of Sample Information Wait for No Patient
|
Eckermann, Simon
|
|
2008
|
11 |
Supplement 1 |
p. 522-526
5 p.
|
artikel
|
| 227 |
Treatment Costs and Health Care Utilization for Patients with Bipolar Disorder in a Large Managed Care Population
|
Guo, Jeff J.
|
|
2008
|
11 |
Supplement 1 |
p. 416-423
8 p.
|
artikel
|
| 228 |
Using Triple Antiplatelet Therapy in Patients with Non-ST Elevation Acute Coronary Syndrome Managed Invasively: A Cost-Effectiveness Analysis
|
Latour-Pérez, Jaime
|
|
2008
|
11 |
Supplement 1 |
p. 853-861
9 p.
|
artikel
|
| 229 |
Validity, Feasibility and Acceptability of Time Trade-Off and Standard Gamble Assessments in Health Valuation Studies: A Study in a Multiethnic Asian Population in Singapore
|
Wee, Hwee-Lin
|
|
2008
|
11 |
Supplement 1 |
p. S3-S10
8 p.
|
artikel
|
| 230 |
Variable Access to Clopidogrel in a Harmonized EU Market
|
Stolk, Pieter
|
|
2008
|
11 |
Supplement 1 |
p. 989-995
7 p.
|
artikel
|
| 231 |
WH4 PROBIOTICS IN PREGNANCY:A SYSTEMATIC REVIEWAND META-ANALYSIS OF THE SAFETY OF LACTOBACILLUS, BIFIDOBACTERIUM AND SACCHAROMYCES
|
Dugoua, JJ
|
|
2008
|
11 |
Supplement 1 |
p. A27-A28
nvt p.
|
artikel
|
Tijdschrift beschrijving